Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001130166-04-000003
Filing Date
2004-06-24
Accepted
2004-06-24 19:16:38
Documents
1
Period of Report
2004-06-22

Document Format Files

Seq Description Document Type Size
1 lan4.html 4  
1 lan4.xml 4 4621
  Complete submission text file 0001130166-04-000003.txt   6171
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1124 COLUMBIA STREET #130 SEATTLE WA 98103
Business Address
LANGECKER PETER (Reporting) CIK: 0001282829 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 04880562